US · USD
IDXX
IDEXX Laboratories Inc
- Day's range
- US$516.02 – US$524.02
- Day's volume
- US$149.2m
- 52-week range
- US$504.70 – US$766.68
Follow IDXX on Fuolio
See how IDXX weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountIDXX in numbers
- Market cap
- US$40.8bn
- P/E
- 35.83
- P/B
- 25.33
- Dividend yield (12m)
- 0.00%
- Net debt/EBITDA
- 0.16
IDXX trades at 35.83 times its earnings of the last 12 months.
IDXX price history
IDXX risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -31.15% | +11.29% | -14.75% |
| Volatility (annualised) | 19.13% | 30.79% | 35.20% |
| Largest drawdown | -31.15% | -31.15% | -50.52% |
| Positive months | 2/12 | 15/36 | 26/60 |
How much did investing in IDXX return?
US$1,000.00 invested on 01/11/2021 would be worth US$852.52 today.
- Value today in IDXX
- US$852.52
- Return over the period
- -14.75%
- Return per year
- -3.19%
- In the S&P 500
- US$1,690.98
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
IDXX fundamentals
Valuation
- P/E35.83
- P/B25.33
- EV/EBITDA25.48
- EV/EBIT28.17
- EV/Revenue9.02
- P/EBIT28.00
- P/S8.97
- P/OCF29.78
- P/FCF32.56
- Earnings yield3.55%
- PEG ratio—
- Earnings per shareUS$14.47
- Book value per shareUS$20.47
Debt
- Net debtUS$252.9m
- Net debt/EBITDA0.16
- Net debt/Equity0.16
- Debt/Equity0.28
- Current ratio1.17
- Quick ratio0.87
- Cash ratio0.15
Efficiency
- Gross margin62.45%
- EBITDA margin35.42%
- Operating margin32.03%
- Net margin25.03%
- Asset turnover1.32
Profitability
- ROE70.67%
- ROA33.11%
- ROIC62.56%
- Payout0.00%
Growth
- Revenue CAGR (5 years)8.37%
- Earnings CAGR (5 years)9.38%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is IDXX's fair price?
Two classic value formulas, with today's numbers. The current price is US$518.39.
- Graham's fair price
- US$81.62
- 84.25% below the price
√(22.50 × US$14.47 × US$20.47)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to IDXX: it paid no distributions in the last five years.
Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.
Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.
IDXX indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 50.84 | 37.87 | 54.58 | 49.80 | 74.48 | 73.40 | 52.10 | 42.43 |
| P/B | 33.55 | 21.08 | 31.07 | 55.56 | 80.40 | 67.56 | 125.55 | -1,681.80 |
| EV/EBITDA | 35.97 | 26.98 | 38.25 | 34.11 | 54.20 | 54.68 | 35.72 | 28.68 |
| Earnings per share | US$13.31 | US$10.92 | US$10.17 | US$8.19 | US$8.84 | US$6.81 | US$5.01 | US$4.38 |
| Book value per share | US$20.16 | US$19.62 | US$17.87 | US$7.34 | US$8.19 | US$7.40 | US$2.08 | -US$0.11 |
| ROE | 65.99% | 55.65% | 56.92% | 111.56% | 107.95% | 92.04% | 241.01% | -3,963.32% |
| ROIC | 58.03% | 46.90% | 50.55% | 56.08% | 55.10% | 52.80% | 57.61% | 86.39% |
| Gross margin | 61.80% | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% | 56.73% | 56.10% |
| EBITDA margin | 34.97% | 32.28% | 33.11% | 30.01% | 32.24% | 29.21% | 26.63% | 25.96% |
| Net margin | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% | 21.49% | 17.77% | 17.04% |
| Net debt/EBITDA | 0.18 | 0.26 | 0.20 | 0.65 | 0.68 | 0.66 | 0.95 | 0.83 |
IDXX financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | US$4.3bn | US$3.9bn | US$3.7bn | US$3.4bn | US$3.2bn | US$2.7bn |
| Cost of sales | -US$1.6bn | -US$1.5bn | -US$1.5bn | -US$1.4bn | -US$1.3bn | -US$1.1bn |
| Gross profit | US$2.7bn | US$2.4bn | US$2.2bn | US$2bn | US$1.9bn | US$1.6bn |
| EBITDA | US$1.5bn | US$1.3bn | US$1.2bn | US$1bn | US$1bn | US$790.5m |
| EBIT | US$1.4bn | US$1.1bn | US$1.1bn | US$898.8m | US$932m | US$694.5m |
| Net finance result | — | — | — | — | — | — |
| Profit before tax | US$1.3bn | US$1.1bn | US$1.1bn | US$860m | US$902.7m | US$662m |
| Income tax | -US$264.7m | -US$222m | -US$216.1m | -US$180.9m | -US$157.8m | -US$79.9m |
| Net income | US$1.1bn | US$887.9m | US$845m | US$679.1m | US$744.8m | US$581.8m |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does IDXX pay dividends?
IDXX has no distributions on record.
About Idexx Laboratories
- Sector
- Manufacturing
Questions about IDXX
How much is IDXX today?
IDXX is at US$518.39 (0.12% on the day), last traded on 02/10/2026.
What are the P/E and P/B of IDXX?
IDXX trades at a P/E of 35.83 and a P/B of 25.33.
How much did IDXX return in 12 months?
IDXX returned -31.15% in 12 months, with annualised volatility of 19.13% and a largest drawdown of -31.15%.